Form 4: Expensify Director Sells 10,000 Shares
Statement of Changes in Beneficial Ownership
Director Carlos Eduardo Alvarez Divo sold 10,000 shares of Expensify, Inc. Class A Common Stock via a 10b5-1 trading plan.
Summary
- Director Carlos Eduardo Alvarez Divo sold 10,000 shares of Expensify, Inc. (EXFY) Class A Common Stock.
- The shares were sold at a weighted average price of $1.13 per share.
- The transaction occurred on May 15, 2026.
- The sale was executed under a Rule 10b5-1 trading plan adopted on December 31, 2025.
- Following the transaction, the director retains 244,780 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed through a pre-planned 10b5-1 mechanism and represents a minor reduction in the director's total position.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which typically indicates the sale is for personal liquidity rather than a reaction to non-public information.
Negatives
- Insider selling can sometimes be perceived by the market as a lack of confidence in the short-term stock performance.
Risks
- The stock price is currently trading at a low valuation level ($1.13 per share), which may reflect broader market concerns regarding the company's growth trajectory.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Industry Context
StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for corporate executives and directors to manage personal financial portfolios, and it is generally viewed as neutral unless the volume of shares sold represents a significant portion of the insider's total holdings.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for corporate insiders to avoid potential accusations of insider trading.
- The sale of 10,000 shares represents a small fraction of the director's total holdings, which is consistent with routine portfolio rebalancing.
Stakeholder Impact
- Shareholders should note the director's continued significant ownership stake of 244,780 shares.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 2025-12-31 | Date the Rule 10b5-1 trading plan was adopted. |
| 2026-05-15 | Date of the reported stock sale transaction. |
| 2026-05-28 | Date the Form 4 was filed with the SEC. |
Keywords
Expensify, EXFY, Insider Trading, Form 4, Director Sale, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.